Q Chip Ltd is a biopharmaceutical company developing sustained release injectable depot formulations. Q Chip’s proprietary encapsulation technology platform, Q-SpheraTM, represents a paradigm shift in bioencapsulation technology for the production of drug loaded microspheres.

Q Chip has developed a suite of manufacturing devices which enable the benign processing of polymer/drug formulations into mono-dispersed microspheres for subcutaneous, intra-muscular/ocular administration. These devices are compatible with a wide range of therapies including small molecules, peptides, oligonucleotides, proteins and cells. In addition, microsphere formulation can also be customised to provide sustained release over weeks or months.